Cortex Pharmaceuticals, Inc.
Adult ADHD study with CX717 shows positive results, reports Cortex
Published in Mental Health Business Week, April 8th, 2006
Forty-nine patients with ADHD completed the randomized, double-blind, placebo-controlled, 2-way crossover design performed at 7 U.S. sites. Cortex undertook this phase IIa clinical trial to assess both the dose of drug required and the effectiveness of CX717 in an adult ADHD population. The primary outcome measure was the ADHD Rating Scale (ADHD-RS) which evaluates both the inattentiveness and hyperactivity symptoms.
The overall ADHD-RS score showed a positive trend in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- John Wiley & Sons, Inc.
Disclosing study outcomes to participants may backfire - Neurogen Corporation
Neurogen Corporation announces $10.6 million net loss for the fourth quarter of 2005 - Neuromed Pharmaceuticals Ltd.
Neuromed raises US$25 million, completing fourth-round private equity financing - Nordic Naturals, Inc.
Nutritional and program interventions improve functional behaviors among Mexican orphans - StemCells, Inc.
Oregon IRB approves phase 1 trial using purified human neural stem cells in Batten disease - Amarin Corp. plc
Amarin reports Miraxion improves stress hormone transport - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
